4.5 Article

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide

Related references

Note: Only part of the references are listed.
Letter Clinical Neurology

Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis

Vittorio Mantero et al.

JOURNAL OF NEUROLOGY (2021)

Article Clinical Neurology

Wilhelm Uhthoff and Uhthoff's phenomenon

Aarushi Jain et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Infectious Diseases

The epidemiology, diagnosis and treatment of COVID-19

Pan Zhai et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Editorial Material Clinical Neurology

Neurology in the time of COVID-19

Hadi Manji et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Clinical Neurology

Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS

Jean-Baptiste Davion et al.

NEUROLOGY (2020)

Article Clinical Neurology

COVID-19 in teriflunomide-treated patients with multiple sclerosis

Amir Hadi Maghzi et al.

JOURNAL OF NEUROLOGY (2020)

Review Clinical Neurology

Central nervous system manifestations of COVID-19: A systematic review

Ali A. Asadi-Pooya et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Review Public, Environmental & Occupational Health

Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review

Tomas Kalincik

NEUROEPIDEMIOLOGY (2015)

Review Pharmacology & Pharmacy

Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

Amit Bar-Or et al.

DRUGS (2014)

Article Clinical Neurology

Uhthoff's Phenomenon in Multiple Sclerosis and Neuromyelitis Optica

Kwiyoung Park et al.

EUROPEAN NEUROLOGY (2014)